Gold Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
100,048
+2,490
| +3% | +$38.3K | 0.58% | 60 |
|
|
2025
Q1 | $1.45M | Buy |
97,558
+15,411
| +19% | +$229K | 0.61% | 62 |
|
|
2024
Q4 | $1.09M | Buy |
82,147
+8,943
| +12% | +$118K | 0.46% | 68 |
|
|
2024
Q3 | $1.05M | Buy |
73,204
+1,428
| +2% | +$20.5K | 0.44% | 68 |
|
|
2024
Q2 | $929K | Buy |
71,776
+1,453
| +2% | +$18.8K | 0.39% | 73 |
|
|
2024
Q1 | $977K | Buy |
70,323
+659
| +0.9% | +$9.15K | 0.39% | 70 |
|
|
2023
Q4 | $994K | Buy |
+69,664
| New | +$994K | 0.43% | 70 |
|